Prosecution Insights
Last updated: May 29, 2026

Examiner: BICKHAM, DAWN MARIE

Tech Center 1600 • Art Units: 1685

This examiner grants 48% of resolved cases

Performance Statistics

48.3%
Allow Rate
-11.7% vs TC avg
66
Total Applications
+74.0%
Interview Lift
1570
Avg Prosecution Days
Based on 29 resolved cases, 2023–2026

Rejection Statute Breakdown

16.8%
§101 Eligibility
11.2%
§102 Novelty
51.8%
§103 Obviousness
1.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17765929 STRESS ANALYSIS APPARATUS, STRESS ANALYSIS METHOD, AND COMPUTER-READABLE RECORDING MEDIUM Final Rejection NEC Corporation
19236435 METHOD AND DEVICES FOR AGE DETERMINATION Final Rejection Thomas J.C. Matzen GmbH
17482575 COMPUTATIONAL CLASSIFICATION BASED ON DNA SEQUENCE SIGNATURES Non-Final OA International Business Machines Corporation
18096868 Estimation of Admixture Generation Final Rejection 23andMe, Inc.
19077065 DIFFUSION-BASED GENERATIVE AI METHODS FOR PROTEIN AND DRUG DESIGN Non-Final OA DEEP EIGENMATICS, INC.
17608548 SAMPLE ANALYSIS METHOD AND DEVICE BASED ON KERNEL MODULE IN GENOMIC MODULE NETWORK Final Rejection Industry-University Cooperation Foundation Hanyang University
19040239 PREDICTION METHOD AND PREDICTION SYSTEM FOR MRKH SYNDROM, AND DEVICE Non-Final OA PEKING UNION MEDICAL COLLEGE HOSPITAL, CHINESE ACAEMY OF MEDICAL SCIENCES
17439900 COMPUTER-IMPLEMENTED METHOD FOR COLLABORATIVE DEVELOPMENT OF REAGENTS FOR DETECTION OF TARGET NUCLEIC ACIDS Non-Final OA SEEGENE, INC.
17434455 METHODS FOR DETERMINING A DESIGNABLE REGION OF OLIGONUCLEOTIDES Non-Final OA SEEGENE, INC.
17510882 PEPTIDE-BASED VACCINE GENERATION Non-Final OA NEC Laboratories America, Inc.
18089565 IDENTIFICATION SYSTEM OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, DEVELOPMENT METHOD OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, CANCER DETECTION METHOD AND KIT Non-Final OA Industrial Technology Research Institute
17804895 METHOD AND SYSTEM FOR PREDICTING MUTATIONS IN RIBONUCLEIC ACID STRAINS Non-Final OA Wipro Limited
17644339 SYSTEM FOR PATHOGENICITY PREDICTION OF GENOMIC VARIANT USING KNOWLEDGE TRANSFER Final Rejection 3BILLION
17772832 METHODS FOR THE CHARACTERIZATION OF FLUID Non-Final OA NextGen Jane, Inc.
17799621 PANOMIC GENOMIC PREVALENCE SCORE Non-Final OA Caris MPI, Inc.
17629766 METHODS OF IDENTIFYING DOPAMINERGIC NEURONS AND PROGENITOR CELLS Non-Final OA Aspen Neuroscience, Inc.
17860169 PET GENOME-BASED MATCHMAKING SOCIAL NETWORK SYSTEM AND METHOD FOR PROVIDING PET GENOME-BASED MATCHMAKING INFORMATION Non-Final OA CLINOMICS INC.
17766018 Biomarker Panels for Guiding Dysregulated Host Response Therapy Non-Final OA Endpoint Health Inc.
17438462 METHODS FOR DETECTING AND CHARACTERIZING MICROSATELLITE INSTABILITY WITH HIGH THROUGHPUT SEQUENCING Non-Final OA Sophia Genetics S.A.
17629091 A METHOD TO ASSIST IN THE EARLY DIAGNOSIS OF PANCREATIC ADENOCARCINOMA Non-Final OA UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA
17556493 LIFECYCLE ASSESSMENT SYSTEMS AND METHODS FOR DETERMINING EMISSIONS FROM ANIMAL PRODUCTION Non-Final OA Low Carbon Technologies, LLC
17617667 METHOD FOR DETECTING GUT DYSBIOSIS OF INFANT Non-Final OA CJ Bioscience. Inc
17500766 DIAGNOSTIC SYSTEM USING DIFFRACTION ANALYSIS OF IN VITRO SAMPLES Non-Final OA Arion Diagnostics, Inc.
17497652 METHODS AND SYSTEMS FOR THE DIAGNOSIS AND TREATMENT OF SEX HORMONE DISORDERS Final Rejection Function Promoting Therapies LLC
17442840 SYSTEMS AND METHODS FOR KARYOTYPING BY SEQUENCING Final Rejection CytoTerra, Inc.
17378404 NEURAL NETWORK ARCHITECTURES FOR LINKING BIOLOGICAL SEQUENCE VARIANTS BASED ON MOLECULAR PHENOTYPE, AND SYSTEMS AND METHODS THEREFOR Final Rejection Deep Genomics Incorporated

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month